1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: IM-T-hA20-08, NCT00546793
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSU-09024, NCI-2011-03150, NCT00989586
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: IM-T-hA20/90Y-hLL2-01, NCT01101581
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1001010838, NCT01147393
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 16 to 65 Sponsor: Other Protocol IDs: 6125, NCT01279707
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: IM-T-HA20-01, NCT00112970
|